Source / Disclosures
The authors do not report any relevant financial disclosures.
Compared with conventional treatment, bariatric surgery excelled in achieving remission from prediabetes and type 2 diabetes and reducing cardiac metabolic risks for patients with obesity, researchers report in Obesity medicine.
according to antôNew Carlos Sobral SouzaPh.D., Ph.D., FACCD., chair of the Department of Cardiology at the Federal University of Sergipe in Brazil, and fellow researchers, scattered data in the literature indicate whether bariatric surgery will achieve better outcomes than long-term comorbidities with diabetes mellitus among users of the public health care system in Brazil. Researchers conducted the study to determine remission of type 2 diabetes and reduction of cardiac metabolic risk at 5 years among obese and type 2 diabetic patients who underwent bariatric surgery and were followed up in the public health care system.
The observational, retrospective, single center study included 38 patients who received conventional medical treatment and 33 patients who underwent bariatric surgery. The researchers evaluated socioeconomic, lifestyle, anthropometric, biochemical, pharmacological, cardiovascular, and glycemic factors. Baseline characteristics between groups were comparable. Overall, 91.6% of patients were women, and the mean age was 46.1 years. Among those who underwent bariatric surgery, there was a mean of 28.3 months to wait for surgery, and 93.9% underwent gastric bypass.
antôNew Carlos Sobral Souza
The results indicated that patients who underwent bariatric surgery showed a higher level of educational attainment (s = .001), higher prevalence of social drinking (s = .006) and a higher BMI (s <.001) compared to the conventional approach arm.
At 5 years, 66.7% of patients who underwent bariatric surgery had fully recovered from type 2 diabetes and 60.6% experienced remission from CDR, while in the conventional treatment arm, 2.6% of patients had remission from diabetes from Type 2 and 18.4% had remission of cardiovascular risk (s <.0001 for both).
“Bariatric surgery outperforms conventional treatment in promoting remission of prediabetes/type 2 diabetes, reducing cardiac metabolic risks and number of drugs used, as well as improving human biochemical and biomarkers for patients with obesity and type 2 diabetes,” de Almeida and colleagues concluded. “Future studies may analyze how long these benefits achieved in the first five years after bariatric surgery persist in individuals with lower social and educational levels.”